Gene · 6788
STK3: serine/threonine kinase 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. STK3: serine/threonine kinase 3. Genes, record 6788. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6788
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13188 | Serine/threonine-protein kinase 3 | 491 | 11 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 12381 | Q13188 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 13524 | Q13188 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 13524 | Q13188 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 12381 | Q13188 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 36709 | Q13188 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 36709 | Q13188 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 36709 | Q13188 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 7379 | Q13188 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 77871 | Q13188 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 180842 | Q13188 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,155
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | STK3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 17 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 10 | 2025 |
| T32DK007028 | Training Program in Endocrinology | 7 | 2025 |
| R01EY015708 | Control of Cell Number in Developing Retina | 6 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P30DK040561 | Boston Area Nutrition Obesity Research Center (NORC) | 5 | 2025 |
| R35GM118063 | Cell signaling in development and regeneration | 5 | 2025 |
| T32CA009110 | Training in Areas Fundamental to Cancer Research | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,155Source NIH's project files
See all 1,155 nih grantsPapers1,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output. | Cold Spring Harb Perspect Biol | 2026 | 42575696 | PubTator, text mining | PubMed |
| Alteration in the Yap Signaling Pathway in Cataractous Human Lens Epithelium. | Curr Eye Res | 2026 | 42494054 | PubTator, text mining | PubMed |
| TEAD1 condensates are transcriptionally inactive storage sites on the pericentromeric heterochromatin in cancer cells. | Nat Cell Biol | 2026 | 42277434 | PubTator, text mining | PubMed |
| Kinase condensates enrich ATP and trigger autophosphorylation. | Cell Rep | 2026 | 42225071 | PubTator, text mining | PubMed |
| The Regulation and Function of Hippo/YAP Pathway in Cancer. | FASEB J | 2026 | 41924992 | PubTator, text mining | PubMed |
| Interaction of mtROS-Immune-Inflammatory Vicious Cycle Activation in Sepsis-Induced Cardiomyopathy. | Clin Exp Pharmacol Physiol | 2026 | 41905969 | PubTator, text mining | PubMed |
| Strip1 Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy. | Cells | 2026 | 41892331 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma. | Cell Mol Life Sci | 2026 | 41863623 | PubTator, text mining | PubMed |
| The EHMT2-MBLAC2 axis suppresses ribosomal DNA transcription in response to nucleolar DNA damage. | Cell Death Dis | 2026 | 41851073 | PubTator, text mining | PubMed |
1 to 10 of 1,840
See all 1,840 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6788
GET https://conductscience.org/api/genes/v1/6788/patents?page=2